Phase II study of carboplatin and pemetrexed in patients with recurrent platinum sensitive ovarian, fallopian tube or primary peritoneal cancer.
Phase of Trial: Phase II
Latest Information Update: 14 Oct 2017
At a glance
- Drugs Carboplatin; Pemetrexed
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 24 Feb 2012 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 24 Feb 2012 Actual patient number (44) added as reported by ClinicalTrials.gov.
- 24 Feb 2012 Status changed from active, no longer recruiting to completed as reported by Clinicaltrials.gov.